Clinical Trial Update: A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM [Phase 3]

View source ↗

Summary

Phase 3 trial update on DBPR108 combined with metformin for Type 2 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DBPR108 (DBPR108)
• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED